Oncolytics Biotech Statistics
Total Valuation
ONCY has a market cap or net worth of $47.50 million. The enterprise value is $37.15 million.
Important Dates
The last earnings date was Friday, March 7, 2025, before market open.
Earnings Date | Mar 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ONCY has 86.42 million shares outstanding. The number of shares has increased by 13.10% in one year.
Current Share Class | n/a |
Shares Outstanding | 86.42M |
Shares Change (YoY) | +13.10% |
Shares Change (QoQ) | +0.72% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 82.98M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 11.42 |
P/TBV Ratio | 11.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.18.
Current Ratio | 2.82 |
Quick Ratio | 2.39 |
Debt / Equity | 0.18 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -189.05% and return on invested capital (ROIC) is -124.82%.
Return on Equity (ROE) | -189.05% |
Return on Assets (ROA) | -74.11% |
Return on Invested Capital (ROIC) | -124.82% |
Return on Capital Employed (ROCE) | -259.13% |
Revenue Per Employee | n/a |
Profits Per Employee | -$787,092 |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, ONCY has paid $90,351 in taxes.
Income Tax | 90,351 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.67% in the last 52 weeks. The beta is 1.49, so ONCY's price volatility has been higher than the market average.
Beta (5Y) | 1.49 |
52-Week Price Change | -48.67% |
50-Day Moving Average | 0.70 |
200-Day Moving Average | 0.93 |
Relative Strength Index (RSI) | 27.18 |
Average Volume (20 Days) | 215,861 |
Short Selling Information
Short Interest | 3.00M |
Short Previous Month | 2.97M |
Short % of Shares Out | 3.61% |
Short % of Float | n/a |
Short Ratio (days to cover) | 9.70 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -24.31M |
Pretax Income | -20.29M |
Net Income | -22.04M |
EBITDA | -24.24M |
EBIT | -24.31M |
Earnings Per Share (EPS) | -$0.29 |
Full Income Statement Balance Sheet
The company has $11.08 million in cash and $739,485 in debt, giving a net cash position of $10.34 million or $0.12 per share.
Cash & Cash Equivalents | 11.08M |
Total Debt | 739,485 |
Net Cash | 10.34M |
Net Cash Per Share | $0.12 |
Equity (Book Value) | 4.16M |
Book Value Per Share | 0.05 |
Working Capital | 8.47M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$18.74 million and capital expenditures -$166,106, giving a free cash flow of -$18.98 million.
Operating Cash Flow | -18.74M |
Capital Expenditures | -166,106 |
Free Cash Flow | -18.98M |
FCF Per Share | -$0.22 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |